Wuhan Hiteck Biological Pharma Co Ltd
SZSE:300683

Watchlist Manager
Wuhan Hiteck Biological Pharma Co Ltd Logo
Wuhan Hiteck Biological Pharma Co Ltd
SZSE:300683
Watchlist
Price: 32.68 CNY -1.89% Market Closed
Market Cap: ¥4.3B

Profitability Summary

Wuhan Hiteck Biological Pharma Co Ltd's profitability score is 27/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

27/100
Profitability
Score
27/100
Profitability
Score

Margins

Earnings Waterfall
Wuhan Hiteck Biological Pharma Co Ltd

Margins Comparison
Wuhan Hiteck Biological Pharma Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Wuhan Hiteck Biological Pharma Co Ltd
SZSE:300683
4.3B CNY
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
392.6B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
171.1B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.1B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.5B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Wuhan Hiteck Biological Pharma Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Wuhan Hiteck Biological Pharma Co Ltd
SZSE:300683
4.3B CNY
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
392.6B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.9B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
171.1B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
121.1B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.5B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
88.6B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Wuhan Hiteck Biological Pharma Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate